CV Stock Analysis: Buy, Sell, or Hold?
CV - CapsoVision, Inc. Common Stock
$7.44
0.79 (11.88%)
▲
5d:
-1.2%
30d:
+43.35%
90d:
-30.4%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When CV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CV is currently trading at $7.44, which is considered extended relative to its 30-day fair value range of $4.94 to $7.23.
Technical Outlook: Technically, CV is in a downtrend. Immediate support is located at $5.84, while resistance sits at $9.17. The stock is showing strong short-term momentum, up 11.9% recently.
Market Sentiment: CV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.50 (+57.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CV is in a downtrend. Immediate support is located at $5.84, while resistance sits at $9.17. The stock is showing strong short-term momentum, up 11.9% recently.
Market Sentiment: CV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.50 (+57.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$4.94 -
$7.23
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.9%)
- BULLISH: Trading 57.9% below Wall St target ($10.50)
Fair Price Analysis
30-Day Fair Range
$4.94 -
$7.23
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$5.84
Resistance Level
$9.17
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.00
Wall Street Target
$10.50
(+57.9%)
Revenue Growth (YoY)
13.5%
Profit Margin
-186.8%
Share & Embed Analysis
Last updated: April 02, 2026 3:48 PM ET
Data refreshes hourly during market hours. Next update: 4:48 PM
Data refreshes hourly during market hours. Next update: 4:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CV showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |